CAS:1903008-80-9 Lazertinib
NAME:Lazertinib CAS:1903008-80-9 MF:Lazertinib MW:554.64 PURITY:98%
Categories：
Material Chemistry
Email：sale06@alfachem.cn
Product introduction
| NAME | Lazertinib |
| CAS | 1903008-80-9 |
| MF | Lazertinib |
| MW | 554.64 |
| DENSITY | 1.27±0.1 g/cm3 |
| STORAGE | Store at -20°C |
Description
Lazertinib (LECLAZA ®) is an oral, third-generation, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) being developed by Yuhan and Janssen Biotech for the treatment of non-small cell lung cancer (NSCLC) . It is a brain-penetrant, irreversible EGFR-TKI that targets the T790M mutation and activating EGFR mutations Ex19del and L858R, while sparing wild type-EGFR
Key words:
Related Products
![CAS: 2469735-68-8 | methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate](https://omo-oss-image.thefastimg.com/portal-saas/new2023101110015359950/cms/image/2eec51cc-aac6-4822-b35d-7b7594822aa7.jpg "CAS: 2469735-68-8 | methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate")
Related Products
Inquiry
Phone/WhatsApp:
Email:
Through its excellent service and product qualities, VT Chemical has cooperated with many famous customers all over the world, eg. TCI, Covestro, etc.
HUATAO GROUP
Leave Message
SAF Coolest v1.3.1.2 设置面板 MFBSX-AJYI-DZAAE-ZAQ
无数据提示
Sorry, the current column is being updated, please look forward to it!
You can view other columns